Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review
- PMID: 1571714
Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review
Abstract
Three patients with acute leukemia who underwent autologous bone marrow transplantation (BMT) in complete remission, developed a severe respiratory syncytial virus (RSV) pneumonia, which was fatal in two. Identification of RSV was made on the products of bronchoalveolar lavage by direct immunofluorescence. As already described by others, the initial course of RSV infection varies, depending on whether it occurs sooner or later after BMT with a better prognosis in the latter situation. Treatment consists of aerosolized ribavirin. Infection by RSV is caused by manual contact with infected persons and contaminated surfaces. The severity of lung RSV infection in the course of BMT suggests the need for prophylactic measures in addition to standard isolation precautions.
Similar articles
-
Successful therapy with ribavirin of late onset respiratory syncytial virus pneumonitis complicating allogeneic bone transplantation.Clin Lab Haematol. 1992;14(1):29-32. Clin Lab Haematol. 1992. PMID: 1600691
-
[Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit].Mikrobiyol Bul. 2008 Apr;42(2):359-64. Mikrobiyol Bul. 2008. PMID: 18697436 Turkish.
-
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.Bone Marrow Transplant. 1995 Sep;16(3):393-9. Bone Marrow Transplant. 1995. PMID: 8535312 Clinical Trial.
-
Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.Bone Marrow Transplant. 2001 May;27(10):1071-3. doi: 10.1038/sj.bmt.1703046. Bone Marrow Transplant. 2001. PMID: 11438823 Review.
-
[Treatment of respiratory syncytial virus infections in immunocompromised hematological patients].Ugeskr Laeger. 2000 Aug 28;162(35):4644-7. Ugeskr Laeger. 2000. PMID: 10986889 Review. Danish.
Cited by
-
Community respiratory virus infections in immunocompromised patients with cancer.Am J Med. 1997 Mar 17;102(3A):10-8; discussion 25-6. doi: 10.1016/s0002-9343(97)80004-6. Am J Med. 1997. PMID: 10868137 Free PMC article. Review.
-
Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Clin Microbiol Rev. 1995 Jan;8(1):22-33. doi: 10.1128/CMR.8.1.22. Clin Microbiol Rev. 1995. PMID: 7704893 Free PMC article. Review.
-
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.Influenza Other Respir Viruses. 2015 Jul;9(4):169-78. doi: 10.1111/irv.12313. Influenza Other Respir Viruses. 2015. PMID: 25847510 Free PMC article. Review.
-
Comparison of an immunochromatography test with multiplex reverse transcription-PCR for rapid diagnosis of respiratory syncytial virus infections.J Clin Microbiol. 2004 Oct;42(10):4812-4. doi: 10.1128/JCM.42.10.4812-4814.2004. J Clin Microbiol. 2004. PMID: 15472348 Free PMC article.
-
Genetic variability and molecular epidemiology of respiratory syncytial virus subgroup a strains in Japan determined by heteroduplex mobility assay.J Clin Microbiol. 2004 May;42(5):2048-53. doi: 10.1128/JCM.42.5.2048-2053.2004. J Clin Microbiol. 2004. PMID: 15131169 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials